Description
COMPOSITION: Each vial contains: 4 g piperacillin (as sodium salt) and 0.5 g tazobactam (as sodium salt)
Piperaxis is indicated for the treatment of patients
with moderate to severe infections caused by
Piperacillin resistant Piperacillin/Tazobactam
susceptible, beta-lactamase producing strains of the
microorganisms in the following conditions:
Lower Respiratory tract infections
Urinary tract infections
Pelvic inflammatory disease or post-partum
endometriosis
Appendicitis
Peritonitis
Skin and skin structure infections
Prescription Medicine .
Refer to Product Insert for more Information
PACKING: 4.5gm Vial Injection
